{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:52:47Z","timestamp":1791373967061,"version":"4.3.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Orthopaedic Science"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jos.2026.09.008","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:14:17Z","timestamp":1791371657000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Temporal changes and associated factors for elevated serum gentamicin levels in continuous local antibiotic perfusion (CLAP) therapy: A multicenter analysis"],"prefix":"10.1016","author":[{"given":"Yusuke","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9279-8301","authenticated-orcid":false,"given":"Yasuhiko","family":"Takegami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Fujihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Imagama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jos.2026.09.008_bib1","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2165\/00003495-200666080-00005","article-title":"Antimicrobial agents in orthopaedic surgery: prophylaxis and treatment","volume":"66","author":"Trampuz","year":"2006","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.jos.2026.09.008_bib2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.injury.2017.08.040","article-title":"Fracture-related infection: a consensus on definition from an international expert group","volume":"49","author":"Metsemakers","year":"2018","journal-title":"Injury"},{"issue":"4","key":"10.1016\/j.jos.2026.09.008_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/apm.12687","article-title":"Orthopaedic biofilm infections","volume":"125","author":"Zimmerli","year":"2017","journal-title":"APMIS"},{"issue":"5","key":"10.1016\/j.jos.2026.09.008_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"Li","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jos.2026.09.008_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/10225536221111902","article-title":"Continuous local antibiotic perfusion: a treatment strategy that allows implant retention in fracture-related infections","volume":"30","author":"Maruo","year":"2022","journal-title":"J Orthop Surg"},{"key":"10.1016\/j.jos.2026.09.008_bib22","first-page":"1","article-title":"Continuous Local Antibiotics Perfusion Therapy for Acute Deep Infections after Open Fractures","volume":"2022","author":"Takahara","year":"2022","journal-title":"Case Rep Orthop Res"},{"issue":"1","key":"10.1016\/j.jos.2026.09.008_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-11808-y","article-title":"Clinical outcomes of continuous local antibiotic perfusion in combination with debridement antibiotics and implant retention for periprosthetic hip joint infection","volume":"15","author":"Hieda","year":"2025","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jos.2026.09.008_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.xrrt.2024.04.013","article-title":"Continuous local antibiotic perfusion technique for surgical site infections after shoulder surgery","volume":"4","author":"Shimada","year":"2024","journal-title":"JSES Reviews, Reports, and Techniques"},{"key":"10.1016\/j.jos.2026.09.008_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.artd.2023.101245","article-title":"Novel local antifungal treatment for fungal periprosthetic joint infection with continuous local antibiotic perfusion: A surgical technique","volume":"24","author":"Choe","year":"2023","journal-title":"Arthroplast Today"},{"issue":"2","key":"10.1016\/j.jos.2026.09.008_bib26","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s40121-024-01095-x","article-title":"Efficacy and limitations of continuous local antibiotic perfusion in treating surgical site infections following instrumented spinal surgery: a retrospective multicenter study","volume":"14","author":"Takahashi","year":"2025","journal-title":"Inf Dis Ther"},{"issue":"2","key":"10.1016\/j.jos.2026.09.008_bib27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jiac.2020.09.033","article-title":"A meta-analysis of the target trough concentration of Gentamicin and Amikacin for reducing the risk of nephrotoxicity","volume":"27","author":"Yamada","year":"2021","journal-title":"J Inf Chemother"},{"issue":"1","key":"10.1016\/j.jos.2026.09.008_bib12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jos.2020.11.010","article-title":"A novel treatment strategy using continuous local antibiotic perfusion: a case series of refractory infection caused by hypervirulent Klebsiella pneumoniae","volume":"27","author":"Himeno","year":"2022","journal-title":"J Orthop Sci"},{"issue":"4","key":"10.1016\/j.jos.2026.09.008_bib13","first-page":"1741","article-title":"Potential of continuous local antibiotic perfusion therapy for fracture-related infections","volume":"11","author":"Kosugi","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jos.2026.09.008_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioflm.2025.100316","article-title":"Accurate quantitation of antibiotic penetration through staphylococcal biofilms","volume":"10","author":"Bin","year":"2025","journal-title":"Biofilm"},{"issue":"4","key":"10.1016\/j.jos.2026.09.008_bib29","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/jor.1100040413","article-title":"Antibiotic stability in an implantable pump","volume":"4","author":"Perry","year":"1986","journal-title":"J Orthop Res"},{"issue":"1","key":"10.1016\/j.jos.2026.09.008_bib30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jos.2025.05.007","article-title":"Prognostic factors influencing the occurrence of drug-induced renal dysfunction during continuous local antibiotic perfusion therapy","volume":"31","author":"Fujihara","year":"2026","journal-title":"J Orthop Sci"},{"issue":"4","key":"10.1016\/j.jos.2026.09.008_bib31","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO Clinical Practice Guidelines for Acute Kidney Injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"issue":"2","key":"10.1016\/j.jos.2026.09.008_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-2002-30103","article-title":"Hepatotoxicity of antimicrobial agents","volume":"22","author":"Brown","year":"2002","journal-title":"Semin Liver Dis"},{"issue":"7","key":"10.1016\/j.jos.2026.09.008_bib17","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/jac\/dkr159","article-title":"Hepatic safety of antibiotics used in primary care","volume":"66","author":"Andrade","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.jos.2026.09.008_bib18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jos.2026.09.008_bib32","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s40262-022-01143-0","article-title":"Clinical pharmacokinetics of Gentamicin in various patient populations and consequences for optimal dosing for Gram-Negative infections: an updated review","volume":"61","author":"Hodiamont","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jos.2026.09.008_bib20","series-title":"Guideline for gentamicin dosing in adults. Version 3","year":"2015"},{"issue":"3","key":"10.1016\/j.jos.2026.09.008_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.phrs.2010.04.004","article-title":"Gentamicin-induced nephrotoxicity: Do we have a promising therapeutic approach to blunt it?","volume":"62","author":"Balakumar","year":"2010","journal-title":"Pharmacol Res"},{"issue":"3-4","key":"10.1016\/j.jos.2026.09.008_bib34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3109\/08860229909085109","article-title":"Oxidant Mechanisms in Gentamicin Nephrotoxicity","volume":"21","author":"Walker","year":"1999","journal-title":"Ren Fail"},{"key":"10.1016\/j.jos.2026.09.008_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.944846","article-title":"An In Vivo biomarker to characterize ototoxic compounds and novel protective therapeutics","volume":"15","author":"Bellairs","year":"2022","journal-title":"Front Mol Neurosci"}],"container-title":["Journal of Orthopaedic Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265826002915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265826002915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:14:21Z","timestamp":1791371661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0949265826002915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":25,"alternative-id":["S0949265826002915"],"URL":"https:\/\/doi.org\/10.1016\/j.jos.2026.09.008","relation":{},"ISSN":["0949-2658"],"issn-type":[{"value":"0949-2658","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporal changes and associated factors for elevated serum gentamicin levels in continuous local antibiotic perfusion (CLAP) therapy: A multicenter analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Orthopaedic Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jos.2026.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}